SBA
CFMS

Secrest Blakey & Associates’s Conformis, Inc. Common Stock CFMS Stock Holding History

Secrest Blakey & Associates’s Portfolio CFMS Stock Details CFMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,810
Closed -$60K – 62
2020
Q1 		$60K Buy
3,810
+2,790
+274% +$68.2K 0.16% 54
2019
Q4 		$38K Sell
1,020
-1,686
-62% -$79.9K 0.08% 59
2019
Q3 		$126K Buy
2,706
+1,021
+61% +$61.4K 0.1% 102
2019
Q2 		$184K Sell
1,685
-564
-25% -$46.5K 0.16% 95
2019
Q1 		$162K Hold
2,249
– – 0.16% 91
2018
Q4 		$20K Hold
2,249
– – 0.02% 101
2018
Q3 		$60K Buy
+2,249
New +$61.1K 0.05% 103

Other funds holding CFMS

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Secrest Blakey & Associates's CFMS Position: Q2 2020 in Review

Secrest Blakey & Associates sold out of Conformis, Inc. Common Stock (CFMS) in Q2 2020, closing a stake of 3,810 shares — an estimated $60K sold.

Secrest Blakey & Associates first reported a position in CFMS in Q3 2018 and held it in 7 quarters. The position peaked at $184K in Q2 2019. 68 funds tracked by Wall St. Rank hold CFMS as of Q2 2020.

  • Secrest Blakey & Associates reported no remaining Conformis, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Secrest Blakey & Associates sold 3,810 Conformis, Inc. Common Stock shares in Q2 2020, an estimated $60K.
  • Secrest Blakey & Associates first reported a position in Conformis, Inc. Common Stock in Q3 2018 and held it in 7 quarters.
  • Secrest Blakey & Associates's Conformis, Inc. Common Stock position peaked at $184K in Q2 2019.
  • 68 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q2 2020.

Based on Secrest Blakey & Associates's 13F filing for Q2 2020, filed 12 Aug 2020.